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Abstract 
We have used the additive manufacturing technology of selective laser sintering (SLS), 
together with post SLS heat treatment, to produce porous three dimensional scaffolds from 
the glass-ceramic apatite-wollastonite (A-W). The A-W scaffolds were custom-designed to 
incorporate a cylindrical central channel to increase cell penetration and medium flow to the 
centre of the scaffolds under dynamic culture conditions during in vitro testing and 
subsequent in vivo implantation. The scaffolds were seeded with human bone marrow 
mesenchymal stromal cells (MSCs) and cultured in spinner flasks. Using confocal and 
scanning electron microscopy, we demonstrated that MSCs formed and maintained a 
confluent layer of viable cells on all surfaces of the A-W scaffolds during dynamic culture. 
MSC-seeded, with and without osteogenic pre-differentiation, and unseeded A-W scaffolds 
were implanted subcutaneously in MF1 nude mice where osteoid formation and tissue 
in-growth were observed following histological assessment. The results demonstrate that 
the in vivo biocompatibility and osteo-supportive capacity of A-W scaffolds can be enhanced 
by SLS-custom design, without the requirement for osteogenic pre-induction, to advance 
their potential as patient-specific bone replacement materials. 
 
Keywords 
Apatite-wollastonite, glass-ceramic, selective laser sintering, mesenchymal stromal cells, in 
vivo biocompatibility. 
 
Introduction 
The production of anatomically correct surgical models has paved the way for the 
development of bone grafts designed to patient specific geometries [1, 2]. Solid freeform 
fabrication (SFF) is one of the enabling technology platforms  that is allowing the production 
of three dimensional (3D) scaffolds with complex geometries containing internal 
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architectures for tissue regeneration [3-5]. Scaffolds can be custom-designed for individual 
patients using, for example, data collated from computed tomography (CT) scans, allowing 
for the inclusion of precise structural properties and levels of porosity to mimic the desired 
tissue type [3]. Selective laser sintering (SLS) is one of these SFF technologies and works 
through use of  a laser to consolidate layers of powdered raw material into a 3D structure [6]. 
Simpson et al used SLS in combination with CT scan data to produce a model human phalanx 
from a poly(L-lactide-co-glycolide)/β-tricalcuim-phosphate composite [7] and Mangano and 
co-workers used a custom made SLS titanium blade for treatment of patients with severely 
atrophied posterior mandibles [8]. In addition, fused deposition modelling, another SFF 
technology has been successfully used to produce customized PCL scaffolds to repair critical 
sized complex cranial defects in rabbits [9]. Patient-specific grafts have now been applied 
clinically,  for example Warnke et al successfully repaired an extended mandibular 
discontinuity defect in a human patient using CT data and computer aided design technology 
to create a Teflon model for a titanium mesh cage [10]. This was subsequently filled with 
bone mineral blocks infiltrated with both recombinant human BMP-7 and autologous bone 
marrow prior to transplantation into the mandibular defect; data obtained post-transplantation 
showed significant bone formation throughout the length of the mandible replacement [11]. 
Materials attractive for bone tissue engineering, such as glass-ceramics can also be 
applied to SLS technologies and we have previously used this method to produce bioactive 
3D porous scaffolds from apatite-wollastonite (A-W) glass-ceramic [12, 13]. Coupled with 
excellent biocompatibility and resorption in vivo,  A-W has a high mechanical strength due to 
the fact that the apatite phase lies within a fibrous wollastonite phase that helps block crack 
propagation [14-17]. A-W lends itself particularly well to SLS techniques allowing more 
complex components to be fabricated. The use of such a bioactive material is particularly 
appealing as it forms a direct physical bond to bone via the formation of an apatite layer on 
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the surface of the material helping to improve integration of the graft [14-16, 18, 19]. In 
addition, bone grafts are often seeded with osteoprogenitor cells to accelerate tissue 
regeneration and further integration. Mesenchymal stromal cells (MSCs) can be isolated from 
various adult and foetal tissues and demonstrate tri-lineage potency into osteogenic, 
chondrogenic and adipogenic lineages [20, 21]. Biomaterial scaffolds seeded with MSCs and 
implanted into bone defects are shown to exhibit increased integration compared to un-seeded 
controls [22]; as such MSCs are a prime candidate cell type for orthopaedic tissue 
engineering applications. 
We have previously demonstrated that SLS 3D microporous A-W scaffolds with a 
basic design (bA-W scaffolds) support the attachment, proliferation and osteogenic 
differentiation of human MSCs in vitro [12]. However, microporosity at the levels obtained 
(typically less than 50 µm) does not allow for vascularisation. In the work presented in this 
paper we have used the flexibility of the manufacturing process to produce a model macro- 
and micro-porous structure and assessed its ability to promote vascularisation, with and 
without optimised seeding using osteogenic pre-differentiated and undifferentiated MSCs, in 
a subcutaneous mouse model. The customised A-W design (cA-W scaffolds) contains a 1mm 
diameter central channel, and to promote cell attachment a dynamic culture method has been 
used, with the intention of enhancing the integration and restoration of tissue in vivo.  
 
Materials and methods 
All plasticware were purchased from Corning and all reagents were obtained from Invitrogen 
unless otherwise stated. 
 
 Apatite-wollastonite scaffold production 
A-W glass-ceramic scaffolds were produced as previously described [13]. Briefly, a glass of 
molar composition 7.1MgO·35.5SiO2·7.1P2O5·49.9CaO·0.4CaF2, was produced by mixing 
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the components (BDH Laboratory Supplies) shown in Table 1, followed by heating at 
1450°C (I Temp 15/16, Pyrotherm), followed by shock quenching in water. 3D structures 
were produced by indirect SLS [13].   
bA-W scaffolds were produced by mixing the 45-90µm powder fraction with an 
acrylic binder at 5% w/w composition (3D systems) using an experimental SLS machine, 
described in [23].  The laser sintering parameters were a laser power of 5W, scan speed of 
150mm/s and an initial powder bed depth of 5mm. Consecutive scan lines were overlapped 
by 0.55mm with a spread layer depth of 0.125mm. The ‘green body’ scaffolds were sintered 
and crystallised by heating in a furnace to 779°C for 1 hour with an incremental heat increase 
of 10°C per minute before increasing to 1150°C for another hour (Lenton Thermal Designs), 
after which samples were cooled to room temperature, to produce bars with final dimensions 
of  25x3x2 mm. Subsequent characterisation revealed these had a microporosity of 35-37% 
(assessed by calculating an apparent density from measured dimensions and weight, and 
comparing this to the true density of A-W), flexural strength of 37±5MPa [13] and pore sizes 
up to 50µm [24]. Using a precision cut off machine (Accutom 5, Struers) scaffolds were cut 
to dimension of 3x3x2mm. For the cA-W scaffold production, the 45-90µm and 0-45µm 
glass powder particle fractions were mixed in a 3:1 ratio and then combined with 10% w/w 
acrylic binder. Green parts with dimensions 5x5x2mm with a 1mm diameter cylindrical 
central channel were produced on a modified commercial SLS machine (Sinterstation 2000, 
3D Systems), described in [24].  Scaffolds were made using a laser power of 25W, scan 
speed of 100mm/s and a powder bed depth of 10mm. Successive scan lines were overlapped 
by 0.2mm with a spread  layer depth of 0.12mm. cA-W scaffolds were post processed using 
an identical heat treatment program as that used for the bA-W scaffolds. The nature of the 
crystal phases produced post heat-treatment were identified through X-ray diffraction using a 
Philips Analytical PW3050 X-ray diffractometer at 40keV, wavelength 1.5406 and a scan 
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range from 10-70
o
 2Ɵ. The smaller glass particle sizes in cA-W scaffolds reduced the overall 
microporosity level to 25-27% (with pore sizes up to 50µm), whilst the flexural strength 
increased to 69±10MPa [24]. Both the bA-W and the cA-W scaffolds were sterilized by 
autoclaving at 15psi for 20 minutes at a temperature of 121°C. 
 
Isolation and culture of human MSCs 
Bone samples were obtained from Harrogate District Hospital, Harrogate, UK under 
approval by the Harrogate Local Research Ethics Committee. MSCs were extracted from the 
bone marrow of human femoral heads obtained with informed consent from routine hip 
replacement surgery as previously described [25].  To encourage osteogenic differentiation, 
cells were grown to confluence upon which the medium was replaced with basal medium 
containing osteogenic supplements (50µg/ml L-ascorbic acid phosphate, 5mM 
β-glycerophosphate and 10nM dexamethasone [Sigma-Aldrich]). 
 
Cell seeding and dynamic culture of A-W scaffolds 
Dynamic culture was carried out using 125ml spinner flasks (Techne), mechanized with a 
magnetic stirring platform (StemStirrer). Spinner flasks were coated with a silicone solution 
(Sigmacote, Sigma-Aldrich) to prevent cell attachment to the vessel surface, then sterilized 
by autoclaving. Scaffolds were immersed in basal medium at 37°C for 30 minutes to 
equilibrate, then placed into a non-adherent 96 U-bottomed well plate and the cells were 
pipetted in a volume of 100µl basal medium (1X DMEM, 10% FBS and 1% P/S) onto each 
scaffold. The cells were cultured for one hour before each scaffold was inverted, placed in a 
fresh well and the remaining MSCs from the first wells were re-applied to the scaffolds and 
left for a further hour. Each scaffold was transferred to basal medium, prior to spinner flask 
culture in 30ml basal medium with continual stirring at 30rpm. After 24 hours spinner flask 
culture the basal medium was replaced with osteogenic medium and the media changed every 
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3-4 days, unless otherwise stated. Cells were seeded on scaffolds in triplicate for each 
experimental time point. 
 
Seeding density optimisation and analysis. 
cA-W scaffolds were seeded with 1x10
6
, 1.5x10
6
 or 2x10
6
 MSCs per scaffold and 
proportionally the same number for the bA-W scaffolds at 5x10
5
 or 1x10
6
 MSCs per scaffold. 
Seeded scaffolds were analysed by scanning electron microscopy (SEM, Jeol JSM-6490LV) 
after 24 hours spinner flask culture in basal medium. Scaffolds were fixed overnight with 
2.5% glutaraldehyde in phosphate buffer (77mM Na2HPO4, 23mM NaH2PO4); then 
dehydrated with a graded series of ethanols (30%, 50%, 70%, 90%) for 30 minutes each, 
followed by three changes of 100% ethanol for 30 minutes each.  Subsequently, scaffolds 
were immersed in hexamethyldisilazane (HMDS, Sigma-Aldrich) and left to dry overnight in 
a sealed desiccated container. Scaffolds were placed in an argon atmosphere then either 
sputter coated with gold for 30 seconds at 40mA (Agar) or sputter coated with gold at 2kV 
for 1 minute (Polaron), after which they were analysed by SEM (Jeol JSM-6490LV). 
 
Cell viability determination 
Cell viability was determined using a live/dead assay (Invitrogen), consisting of calcein AM 
and ethidium homodimer-1 fluorescent stains and carried out following the manufacturer’s 
instructions. Cells were visualized using a Zeiss LSM 510 meta on an Axiovert 200M 
confocal microscope. All confocal images are condensed z-stack images. 
 
Subcutaneous implantation of A-W scaffolds in nude mice 
All in vivo experiments were carried out in accordance with ethical guidelines under the 
Home Office project licence of Dr Xuebin Yang, University of Leeds, UK. NIH guidelines 
for the care and use of laboratory animals (NIH Publication #85-23 Rev. 1985) have been 
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observed. cA-W and bA-W scaffolds were seeded with 2x10
6
 and 1x10
6
 MSCs per scaffold 
respectively and transferred to spinner flasks for 24 hours culture in basal medium. Scaffold-
MSCs constructs were either implanted directly or dynamically cultured for a further 6 days 
in osteogenic medium before implantation (Table 2). Control un-seeded cA-W scaffolds were 
also implanted. Four replicates were included for each treatment group. Seven week old male 
MF1 athymic nude mice were anesthetized by intraperitoneal injection with a 1:1 mixture of 
Hypnorm (1:4 in sterile H2O; Leeds, UK)/Hypnovel (1:1 in sterile H2O, Midazolam, Roche) 
(8ml/kg) [26]. A 1 cm incision was made on each side of the back and a subcutaneous pocket 
created by blunt dissection. A single scaffold was inserted into each subcutaneous pocket, 
after which the incision was closed with non-resorbable sutures (5-0 Ethilon, Ethicon). Mice 
were sacrificed after 4 or 8 weeks and the scaffolds analysed by histological staining. 
Scaffolds and surrounding tissue were extracted after 4 weeks and examined for evidence of 
inflammation or vascularisation. 
 
Resin embedding and sectioning 
Following removal from the implant site, scaffolds were fixed in 10% neutral buffered 
formaldehyde for 24 hours, followed by ethanol dehydration (30%, 50%, 70%, 90% and 3 x 
100%) for 30 minutes each. Scaffolds were placed in a 1:1 mixture of 100% ethanol and 
methacrylate resin (Sigma-Aldrich) and agitated for 72 hours, followed by agitation in 100% 
methacrylate resin for a further 48 hours. Scaffolds were then placed in methacrylate resin 
containing 1% w/v benzoyl peroxide (Sigma-Aldrich) and incubated at 50°C overnight to 
allow the resin to polymerize. 300µm sections were cut using a precision cut off machine 
(Accutom-5, Struers). The sections were then polished to a thickness of 100µm using P600 
and P1200 Wet or dry Tri-M-ite (3M). 
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Sanderson’s rapid bone stain 
Sections were stained with Sanderson’s rapid bone stain (Surgipath) for 2 minutes at 55°C 
then washed with dH2O. Sections were then counter-stained with van Gieson (Raymond A. 
Lamb Ltd) for 5 minutes, cleared in xylene for 5 minutes and mounted on glass microscope 
slides with DPX (BDH). Sections were analysed by standard light microscopy (DMLA, 
Leica). 
 
Alcian blue/sirius red staining 
Sections were stained with Weigart’s haematoxylin (equal parts of 1g haematoxylin 
[Surgipath] in 100ml absolute ethanol; and 30% aqueous ferric chloride [BDH], 1ml 
concentrated HCl in 95ml dH2O), then submerged briefly in 1% HCl in absolute methanol. 
After which scaffolds were stained with alcian blue (0.5g alcian blue 8GX [Sigma-Aldrich] 
with 1ml acetic acid in 100ml dH2O) for 10 minutes and treated with 1% phosphomolybdic 
acid for 20 minutes, before staining with sirius red (0.3% sirius red [BDH] in saturated picric 
acid) for 60 minutes. Sections were dehydrated with 100% ethanol, cleaned in xylene for 5 
minutes and mounted on glass microscope slides with DPX. Sections were analysed with 
standard light microscopy (DMLA, Leica). 
 
Results 
Scaffold design and seeding density optimisation 
A-W scaffolds were produced with a basic design (bA-W) and a custom-designed 1mm 
cylindrical central channel (cA-W) (Fig. 1). Fig. 2 shows an exemplary XRD pattern of the 
sintered material, demonstrating that the temperature cycle used produced the desired 
fluorapatite (ICDD 15-876) and wollastonite (ICDD 42-547) phases, with a significant 
residual glassy phase also present.  The weight ratio of these phases has been reported to be 
in the range ~32-35:25-40:25-40 depending upon precise heat treatment [15, 27]. Few surface 
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details of either apatite or wollastonite crystals are visible via SEM; high magnification 
images revealed small domains of interlocked crystals similar to those observed by Kokubo 
et al [27, 28]. Seeding density analysis on cA-W scaffolds was used to optimise initial cell 
seeding numbers; we have previously determined static seeding efficiency on bA-W scaffolds 
[12]; we found that different initial seeding densities were required for bA-W and cA-W to 
generate a confluent monolayer across the scaffolds, avoiding cell stacking and ensuring 
efficient use of the primary cells. This was primarily due to the size and surface area 
difference between bA-W and cA-W scaffolds, and was calculated over three separate 
experiments. MSCs were statically seeded on cA-W scaffolds at densities of 1x10
6
, 1.5x10
6
 
and 2x10
6
 cells per scaffold, dynamically cultured in spinner flasks at 30rpm for 24 hours and 
analysed by SEM (Fig. 3A-C). The results identified that 2x10
6
 cells per scaffold was the 
optimal seeding density. This number gave a confluent layer of cells across the whole surface 
of the scaffold, which would be conducive for osteogenic differentiation. At seeding densities 
of 1x10
6
 or 1.5x10
6
 cells per scaffold bare patches of scaffold in-between confluent areas of 
cells could be observed. A similar process was performed for bA-W scaffolds (Fig. 3D-E) 
and determined that 1x10
6
 cells per scaffold was optimal. The optimal seeding density for 
bA-W scaffolds was also determined by seeding the scaffolds with 5x10
5
 or 1x10
6
 MSCs per 
scaffold, followed by dynamic culture for 24 hours and analysis by SEM (Fig. 3D-E). Here, 
1x10
6
 cells per scaffold were optimal for bA-W scaffolds.    
 
Viability and morphology of MSCs dynamically cultured on cA-W scaffolds 
MSCs were seeded on cA-W scaffolds at a density of 2x10
6
 cells per scaffold and 24 hours 
after spinner flask culture the medium was changed to osteogenic medium. Cell viability was 
determined using a fluorescent live/dead assay and confocal microscopy 0, 7, 14 and 21 days 
after osteogenic induction. The results demonstrated that MSCs remained viable (green 
fluorescence) for up to 21 days when cultured on the scaffolds with minimal compromised 
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cells (Fig. 4). Day 0 is the equivalent of Day 1 in basal media. Scaffolds were analysed by 
SEM at 0, 7, 14 and 21 days after osteogenic induction to determine MSC growth and 
spreading (Fig. 5). The MSCs produced a confluent sheet of elongated spindle-shaped cells 
on all outer surfaces of the scaffold including the central channel after 24 hours culture, and 
maintained confluency for the 3 week culture period. By 14 days culture the central channel 
was completely covered by cells and/or matrix. Results demonstrated that dynamic culture 
was conducive to MSCs adherence, spreading and viability for up to 21 days of dynamic 
culture. Similar results have been seen previously for bA-W scaffolds [12].  
 
Subcutaneous implantation of MSC seeded A-W scaffolds in vivo 
All MSC-seeded scaffolds, extracted 4 weeks after implantation, stained positively for 
osteoid and soft tissues in the pores and around the periphery of the scaffolds using 
Sanderson’s rapid bone stain (Fig. 6). The scaffolds also demonstrated good integration with 
the host soft tissue. However, for both the cA-W and bA-W scaffolds there was no obvious 
difference in the amount of osteoid staining between MSC-seeded scaffolds cultured in basal 
or osteogenic medium. The differences in geometry and porosity of the cA-W and bA-W 
scaffolds seem to have made no significant difference to the amount of osteoid staining. 
There was a greater level of osteoid staining in the central channel and periphery of MSC-
seeded cA-W scaffolds (Fig. 6, C1, C2 and D1, D2) compared to the un-seeded control (Fig. 
6, E1, E2). There was an enhanced level of osteoid staining both in the pores and around the 
periphery of all the scaffolds after 8 weeks implantation (Fig. 7) compared to 4 weeks (Fig. 
6). Cells can be observed attached to the surface of the scaffolds and in the surrounding 
pores. Again, for both the cA-W and bA-W scaffolds there was no obvious difference in the 
amount of staining between MSC-seeded scaffolds cultured in basal or osteogenic medium. 
There was more uniformity of osteoid staining in the central channel of MSC-seeded cA-W 
scaffolds (Fig. 7, C3 and D3) compared to the un-seeded control (Fig. 7, E3). However, the 
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amount of staining in the main body of the seeded and un-seeded cA-W scaffolds was 
similar. Results demonstrate that the scaffolds integrate well into the host tissue and support 
the formation of osteoid particularly in MSC-seeded samples. Importantly, an osteogenic pre-
differentiation step did not enhance osteoid deposition. 
Sectioned scaffolds were stained with alcian blue and sirius red for cartilage and 
collagen matrices respectively. After 4 weeks implantation, positive sirius red staining was 
observed on the surface and in the pores of all the scaffolds (Fig. 8). However, there was no 
positive alcian blue staining. For both the cA-W and bA-W scaffolds there was no obvious 
difference in the amount of staining between MSC-seeded scaffolds cultured in basal or 
osteogenic medium. There was an enhanced level of sirius red staining in the central channel 
of seeded cA-W scaffolds (Fig. 8, C3 and D3) compared to the un-seeded control (Fig. 8, 
E3). In the main body of the scaffolds there also appeared to be more intense red staining in 
the cA-W group (Fig. 8, C2-E2) compared to that in the bA-W group (Fig. 8, A2 and B2), 
indicating that more collagen matrix was deposited within the cA-W scaffolds. However, the 
amount of staining in the main body of the seeded and un-seeded cA-W scaffolds was similar 
(Fig. 8, C2-E2). There was no observable difference in the level of alcian blue/sirius red 
staining in the scaffolds after 8 weeks implantation compared to 4 weeks (data not shown). 
Further to this, macroscopic examination of cA-W scaffolds cultured in vivo for 4 weeks 
showed signs of blood vessels surrounding the scaffold constructs, particularly 
around/towards the central channel (Fig. 9). Results demonstrate that the scaffolds support 
collagen matrix formation in vivo and that cA-W scaffolds may be more conducive to 
collagen matrix deposition and blood vessel localisation due to their macro-porous design. 
 
Discussion 
We aimed to produce an A-W bone replacement scaffold to a specific geometry that would 
support the dynamic culture and in vivo bone forming capacity of human MSCs. We have 
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demonstrated that A-W scaffolds produced by SLS to a specified shape and size could be 
seeded with a confluent layer of cells on all surfaces, and that they remained viable and 
attached to the scaffolds for 21 days of spinner flask culture. cA-W and bA-W scaffolds were 
seeded with MSCs then pre-cultured in either basal or osteogenic medium and implanted 
subcutaneously in nude mice. Good integration with the host tissue and osteoid formation 
was observed in both scaffolds, along with evidence of vascularisation, more so in cA-W 
compared to bA-W. The in vivo experiments were carried out in quadruplicate with 
representative images shown; the observations were reproducible but qualitative and warrant 
further quantitative analysis and statistical testing. 
There was a high level of viability of MSCs after 24 hours of spinner flask culture on 
the cA-W scaffolds, as determined by confocal analysis of live/dead staining, which was 
retained over three weeks of culture. SEM analysis of the cA-W scaffolds demonstrated that 
the MSCs remained attached to the scaffolds as a confluent layer for 3 weeks culture and by 
14 days of dynamic culture the central channel was completely covered by cells and/or 
matrix.  Cell proliferation may have been enhanced by the dynamic culture, an effect which 
has previously been reported [29-31], or the cells may have secreted extracellular matrix into 
the central channel. In addition to this, dynamic spinner flask culture has been shown to 
enhance osteogenic and adipogenic differentiation potential, an effect most likely due to 
changes in cytoskeletal arrangement and gene expression patterns [32]. The confluent nature 
of the cells seeded onto the surface of the scaffold could potentially reduce the flow of 
nutrients and gases between the outer and inner parts of the scaffold and thus affect cell 
penetration; however this does not appear to be the case from our observations in vivo where 
tissue was formed throughout the inner and outer parts of the scaffold. The combined macro 
and micro-porous nature of the cA-W scaffolds supports the theory that macroporosity allows 
enhanced early in-growth and matrix deposition within the central channel whilst the 
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microporosity allows controlled resorption over time, as Fjita et al demonstrated with in vivo 
implantation of microporous A-W scaffolds [33].  
In vivo tissue in-growth was observed in both the cA-W and bA-W scaffolds as 
determined by Sanderson’s rapid bone stain and alcian blue/sirius red staining after 
subcutaneous implantation in nude mice, and resulted in substantial integration with the host 
tissue indicating the potential of enhanced osteointegration for clinical application. It is likely 
that the observed tissue in-growth originated from a combination of implanted cells and cells 
from the surrounding tissue, particularly as A-W is biomimetic and as such encourages cell 
infiltration and attachment. As expected, there was more tissue formation in the 8 week 
samples compared to the 4 week samples, there was also substantial tissue formation 
observed in the central channel of the MSC-seeded cA-W scaffolds, which was greater than 
that observed in the un-seeded controls. All samples supported the formation of osteoid, 
identified by bright green/blue Sanderson’s rapid bone staining.  There was no obvious 
difference in osteoid formation between un-seeded and seeded cA-W scaffolds by week 8, 
however at week 4 there appeared to be a higher level of osteoid deposition in the seeded 
scaffolds compared to the un-seeded scaffolds. These observations suggest that MSC-seeded 
scaffolds enhance initial matrix and osteoid formation to facilitate earlier repair than those 
scaffolds implanted without MSCs. Furthermore, seeded scaffolds showed increased tissue 
formation in the channel of cA-W scaffolds compared to un-seeded cA-W scaffolds, 
demonstrating that populating with MSCs could facilitate a higher rate of tissue formation in 
larger channels and pores. It is thought that pre-differentiating MSCs before in vivo 
implantation can enhance their osteogenic potential [34]. However, we found no difference in 
the tissue forming capacity of MSCs cultured on A-W scaffolds in basal medium for 1 day or 
osteogenic medium for 7 days. This observation aligns itself to other studies where pre-
culture time of MSCs was varied before subcutaneous or cranial implantation into rats, results 
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of which demonstrated that increasing pre-culture time decreased in vivo bone formation [35, 
36]. Macroscopic examination of cA-W scaffolds 4 weeks post implantation revealed blood 
vessel association surrounding the scaffold, particularly near the central channel. Blood 
vessel infiltration would help facilitate successful osteointegration of the construct when 
implanted orthotopically. The differences in fabrication route, geometry and porosity of the 
cA-W and bA-W scaffolds made no significant difference in the degree of osteoid formation 
within the main body or periphery of the scaffold structures.  There was a high degree of 
collagen formation in all samples as determined by sirius red staining; however there was 
more intensive staining in the cA-W group compared to the bA-W group, indicating higher 
collagen matrix deposition within the cA-W scaffolds at four weeks. This may be due to the 
greater cell and nutrient infiltration into the centre of the cA-W scaffolds compared to the 
bA-W due to an increased surface area and accessibility within the centre channel, thus 
facilitating penetration of cells and subsequent tissue regeneration. 
Therefore, optimally MSC pre-seeded custom-designed scaffolds, without osteogenic 
predifferentiation offers an appropriate route for bone replacement using A-W glass-
ceramics. 
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Figure Legends 
 
Figure 1. Structure of bA-W and cA-W scaffolds. bA-W scaffolds were designed with  dimensions of 
3x3x2mm (A) and cA-W scaffolds with dimensions of 5x5x2mm containing a central channel 
(arrows) 1mm in diameter (B). Both of which were produced by SLS. A2 and B2 show SEM images 
to demonstrate the surface structure and porosity of the bA-W and cA-W scaffolds respectively. C1 
shows surface topography of A-W, whilst C2 shows a typical fracture surface of an A-W scaffold, 
demonstrating the internal structure and porosity. Scale bars; A2 and B2 = 1000µm, C1 and C2 = 
200µm. 
 
Figure 2. XRD pattern for cA-W after heat treatment showing apatite (■) and wollastonite (♦) phases, 
referenced from ICCD15-876/42-547. 
 
Figure 3. Optimisation of seeding density on cA-W and bA-W scaffolds for dynamic culture. cA-W 
scaffolds were seeded with 1x10
6
 (A), 1.5x10
6
 (B) or 2x10
6
 (C) MSCs per scaffold and bA-W 
scaffolds were seeded with 5x10
5
 (D) or 1x10
6
 (E) MSCs per scaffold. The scaffolds were analysed 
by SEM after 24 hours dynamic culture in basal medium. Arrows identify sheets of cells and * 
indicates bare A-W scaffold. Scale bars = 500µm (left column) and 200µm (right column), 
representative images shown, n=3. 
 
Figure 4. Cell viability of MSCs dynamically cultured on cA-W scaffolds. MSCs were dynamically 
cultured under osteogenic conditions and their viability was determined using a fluorescent live/dead 
assay under confocal microscopy at 0, 7, 14 and 21 days after induction. The majority of MSCs 
retained viability (left panel; green fluorescence identifies viable cells) for up to 21 days although 
there appeared a few dead cells (the right panel; red fluorescence identifies the nuclei of dead cells). 
Day 0 depicted here is equivalent to Day 1 basal medium. Scale bar = 200µm, representative images 
shown, n=3. 
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Figure 5. Time course SEM analysis of cell growth on cA-W scaffolds. Scaffolds were seeded with 
2x106 MSCs per scaffold and analysed by SEM after 0, 7, 14 and 21 days of dynamic culture in 
osteogenic medium. The MSCs formed a confluent monolayer of cells on all surfaces of the scaffolds 
and by day 14 the central channel (arrows) was covered by cells/matrix, representative images shown, 
n=3. 
 
Figure 6. Sanderson’s rapid bone stain after 4 weeks subcutaneous implantation. bA-W (A, B) and 
cA-W (C, D) scaffolds were seeded with MSCs, cultured for 7 days in osteogenic medium (A and C) 
or 1 day in basal medium (B and D) and implanted subcutaneously in nude mice for 4 weeks. Control 
un-seeded cA-W (E). Positive blue/green staining, particularly in the pores and around the periphery 
of the cell-seeded scaffolds (*), indicates osteoid and soft tissue formation.  A1-E1 and A2-E2 shows 
the interface between the scaffold and newly formed tissue at different magnifications. C3-E3 shows 
the central channel of the cA-W scaffolds. Scale bar = 250µm, representative images shown, n=4. 
 
Figure 7. Sanderson’s rapid bone stain after 8 weeks subcutaneous implantation. bA-W (A, B) and 
cA-W (C, D) scaffolds were seeded with MSCs, cultured for 7 days in osteogenic medium (A and C) 
or 1 day in basal medium (B and D) and implanted subcutaneously in nude mice for 8 weeks. Control 
un-seeded cA-W (E). There was a high level of positive blue/green staining (*) for osteoid and soft 
tissue formation.  A1-E1 and A2-E2 shows the interface between the scaffold and newly formed tissue 
at different magnifications. C3-E3 shows the central channel of the cA-W scaffolds. Scale bar = 
250µm, representative images shown, n=4. 
 
Figure 8. Alcian blue/sirius red staining after 4 weeks subcutaneous implantation. bA-W (A, B) and 
cA-W (C, D) scaffolds were seeded with MSCs, cultured for 7 days in osteogenic medium (A and C) 
or 1 day in basal medium (B and D) and implanted subcutaneously in nude mice for 4 weeks. Control 
un-seeded cA-W scaffolds (E). Positive sirius red staining for collagen was observed.  A1-E1 shows 
the interface between the scaffold and newly formed tissue,  A2-E2 shows matrix deposition within 
the scaffolds and C3-E3 shows the central channel of the cA-W scaffolds. Scale bar = 250µm, 
representative images shown, n=4. 
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Figure 9. Macroscopic examination of implanted scaffolds. There was no sign of inflammation 
around the scaffolds after 4 weeks subcutaneous implantation in nude mice. The scaffolds were well 
integrated with the host tissue. (A) cA-W scaffold, 1 day basal medium. (B) cA-W scaffold, un-seeded 
control. Arrows indicate where blood vessel association with the c-A-W scaffolds can be observed, 
particularly within the central channel, representative images shown, n=4. 
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Table 1. Reagents used to make A-W glass. 
 MgO CaCO3 SiO2 P2O5 CaF2 
Mass (g) 18.4 319.2 136.0 64.8 2.0 
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Table 2. Scaffold groups for subcutaneous implantation in vivo (n = 4). 
Group Scaffold Seeded with 
MSCs 
Culture 
medium 
In vitro culture 
time (days) 
Implantation 
time (weeks) 
A 
B 
C 
D 
E 
F 
G 
H 
I 
J 
bA-W 
cA-W 
bA-W 
cA-W 
cA-W 
bA-W 
cA-W 
bA-W 
cA-W 
cA-W 
+ 
+ 
+ 
+ 
- 
+ 
+ 
+ 
+ 
- 
Osteogenic 
Osteogenic 
Basal 
Basal 
Basal 
Osteogenic 
Osteogenic 
Basal 
Basal 
Basal 
7 
7 
1 
1 
1 
7 
7 
1 
1 
1 
8 
8 
8 
8 
8 
4 
4 
4 
4 
4 
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